United Cannabis (CNAB) VP Tony Verzura Sells 34,502 Shares

United Cannabis (OTCMKTS:CNAB) VP Tony Verzura sold 34,502 shares of the firm’s stock in a transaction dated Monday, May 14th. The stock was sold at an average price of $1.00, for a total value of $34,502.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Tony Verzura also recently made the following trade(s):

  • On Tuesday, May 8th, Tony Verzura sold 52,363 shares of United Cannabis stock. The stock was sold at an average price of $1.01, for a total value of $52,886.63.
  • On Thursday, April 26th, Tony Verzura sold 31,537 shares of United Cannabis stock. The stock was sold at an average price of $1.03, for a total value of $32,483.11.
  • On Tuesday, April 24th, Tony Verzura sold 34,523 shares of United Cannabis stock. The stock was sold at an average price of $1.06, for a total value of $36,594.38.
  • On Friday, April 20th, Tony Verzura sold 8,700 shares of United Cannabis stock. The stock was sold at an average price of $1.08, for a total value of $9,396.00.
  • On Wednesday, April 18th, Tony Verzura sold 97,050 shares of United Cannabis stock. The shares were sold at an average price of $1.16, for a total value of $112,578.00.
  • On Monday, April 16th, Tony Verzura sold 12,262 shares of United Cannabis stock. The shares were sold at an average price of $1.24, for a total value of $15,204.88.
  • On Monday, March 19th, Tony Verzura sold 25,000 shares of United Cannabis stock. The shares were sold at an average price of $1.25, for a total value of $31,250.00.

Shares of CNAB stock traded up $0.01 during midday trading on Thursday, reaching $0.95. 161,400 shares of the company traded hands, compared to its average volume of 331,223. United Cannabis has a 1-year low of $0.54 and a 1-year high of $2.50.

United Cannabis Company Profile

United Cannabis Corporation owns intellectual properties related to growth, production, manufacture, marketing, management, utilization, and distribution of medical marijuana and marijuana infused products in the United States. The company focuses on developing therapeutics, including Prana Bio Nutrient Medicinal products for supplement deficiencies related to the endocannabinoid system, including pain, neuropathy, arthritis, MS, IBS, autism, seizures, eczema, sleep, anxiety, head trauma, opioid dependency, and clinical endocannabinoid deficiencies; and Prana Aromatherapy Transdermal Roll-on line that provides targeted and large surface relief with combinations of aromatherapy.

Insider Buying and Selling by Quarter for United Cannabis (OTCMKTS:CNAB)

Receive News & Ratings for United Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply